Calin Moucha, MD
Adult Reconstructive Orthopaedic Surgery · Newark, NJNPI 1528142197
Payments from drug & device makers
What this record shows
Medical Device Business Services, Inc. accounts for 61.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $4,286 and has fallen 85.1% since, to $640 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NJ, where the typical reported total is $8,051.
Across 29 payments — averaging $217.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$4K
- Johnson & Johnson$998
- Innovation Technologies Inc$333
- Davol Inc.$331
- Smith+Nephew$306
- Stryker$168
- plus $301 from 4 others
What the payments were for
- Consulting fees$3,63057%
- Food & beverage$2,68643%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 3 | $3,878 |
| Johnson & Johnson | 10 | $998 |
| Innovation Technologies Inc | 4 | $333 |
| Davol Inc. | 2 | $331 |
| Smith+Nephew | 3 | $306 |
| Stryker | 2 | $168 |
| Medtronic | 1 | $129 |
| Vertex | 1 | $107 |
| Zimmer Biomet | 2 | $43 |
| Heron Therapeutics, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$616
- ARISTA$331
- Velys$269
- Irrisept$155
- MAKO$150
- Kincise$144
- RECLAIM$135
- Journey II BCS$133
- Journey II CR$133
- VISIONAIRE Cutting Guides$133
- Navio Surgical System$133
- CD HORIZON SPINAL SYSTEM$129
- ACTIS$122
- EMPHASYS$121
- JOURNAVX$107
How this compares
$6,316 in reported general payments places this provider in the 40th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 103 | $3,289 |
| Cefadroxil | 12 | $412 |
| Amoxicillin | 98 | $401 |
| Oxycodone Hcl | 59 | $311 |
| Meloxicam | 94 | $295 |
| Methylprednisolone | 16 | $155 |
| Mupirocin | 19 | $147 |
| Gabapentin | 15 | $114 |
| Prednisone | 21 | $91 |
| Tramadol Hcl | 27 | $82 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Newark
- Zuhdi AbdoNewark$12K
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.